Literature DB >> 12117876

New steroids for IBD: progress report.

S B Hanauer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12117876      PMCID： PMC1773302          DOI： 10.1136/gut.51.2.182

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  12 in total

Review 1.  Innovations in topical therapy.

Authors:  F Richter; W Scheppach
Journal:  Baillieres Clin Gastroenterol       Date:  1997-03

2.  Further experience in the treatment of severe attacks of ulcerative colitis.

Authors:  S C Truelove; C P Willoughby; E G Lee; M G Kettlewell
Journal:  Lancet       Date:  1978-11-18       Impact factor: 79.321

3.  A comparison of prednisolone enemas with low-dose oral prednisolone in the treatment of acute distal ulcerative colitis.

Authors:  I Hamilton; I F Pinder; R J Dickinson; W S Ruddell; M F Dixon; A T Axon
Journal:  Dis Colon Rectum       Date:  1984-11       Impact factor: 4.585

Review 4.  Review article: older systemic and newer topical glucocorticosteroids and the gastrointestinal tract.

Authors:  A Thiesen; A B Thomson
Journal:  Aliment Pharmacol Ther       Date:  1996-08       Impact factor: 8.171

5.  Budesonide versus prednisolone retention enemas in active distal ulcerative colitis.

Authors:  R Löfberg; O Ostergaard Thomsen; E Langholz; R Schiöler; A Danielsson; O Suhr; H Graffner; L Påhlman; P Matzen; J F Møller-Petersen
Journal:  Aliment Pharmacol Ther       Date:  1994-12       Impact factor: 8.171

Review 6.  Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease.

Authors:  C M Spencer; D McTavish
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

7.  A comparison of budesonide with prednisolone for active Crohn's disease.

Authors:  P Rutgeerts; R Löfberg; H Malchow; C Lamers; G Olaison; D Jewell; A Danielsson; H Goebell; O O Thomsen; H Lorenz-Meyer
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

8.  Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group.

Authors:  G R Greenberg; B G Feagan; F Martin; L R Sutherland; A B Thomson; C N Williams; L G Nilsson; T Persson
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

9.  Intensive intravenous treatment of ulcerative colitis.

Authors:  G Järnerot; P Rolny; H Sandberg-Gertzén
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

Review 10.  Topical treatment of ulcerative colitis.

Authors:  L R Sutherland
Journal:  Med Clin North Am       Date:  1990-01       Impact factor: 5.456
View more
  6 in total

1.  Osteoporosis in inflammatory bowel disease.

Authors:  J Compston
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.

Authors:  Hussain Ali; Benno Weigmann; Eva-Maria Collnot; Saeed Ahmad Khan; Maike Windbergs; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2015-12-30       Impact factor: 4.200

3.  Tranexamic Acid and Supportive Measures to Treat Wasting Marmoset Syndrome.

Authors:  Takuro Yoshimoto; Kimie Niimi; Eiki Takahashi
Journal:  Comp Med       Date:  2016-12-01       Impact factor: 0.982

4.  Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.

Authors:  Mingzhen Zhang; Emilie Viennois; Meena Prasad; Yunchen Zhang; Lixin Wang; Zhan Zhang; Moon Kwon Han; Bo Xiao; Changlong Xu; Shanthi Srinivasan; Didier Merlin
Journal:  Biomaterials       Date:  2016-06-09       Impact factor: 12.479

Review 5.  Stem cells as potential therapeutic targets for inflammatory bowel disease.

Authors:  Udai P Singh; Narendra P Singh; Balwan Singh; Manoj K Mishra; Mitzi Nagarkatti; Prakash S Nagarkatti; Shree Ram Singh
Journal:  Front Biosci (Schol Ed)       Date:  2010-06-01

6.  Development and validation of a rapid HPLC method for simultaneous analysis of budesonide and its novel synthesized hemiesters in colon specific formulations.

Authors:  J Varshosaz; J Emami; N Tavakoli; M Minaiyan; N Rahmani; F Ahmadi; F Dorkoosh
Journal:  Res Pharm Sci       Date:  2011-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.